• Cancer Matters with Dr Bill Nelson - FDA Approval of a Drug Targeting a Brain Cancer Mutation

  • Aug 7 2024
  • Length: 13 mins
  • Podcast

Cancer Matters with Dr Bill Nelson - FDA Approval of a Drug Targeting a Brain Cancer Mutation

Listen for free

View show details

  • Summary

  • Dr Bill Nelson talks with Dr Matthias Holdhoff about the treatment of brain cancer and a significant FDA approval of a new drug treatment for a type of brain cancer, called low-grade glioma. The drug, called vorasidenib, is a targeted cancer therapy that works by inhibiting the activity of a mutated gene called IDH, slowing the growth of the cancer. Read more here

    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Cancer Matters with Dr Bill Nelson - FDA Approval of a Drug Targeting a Brain Cancer Mutation

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available